The study of relationship between Immune-related adverse events with immune checkpoint blockade and microbiota change
Not Applicable
- Conditions
- gastric cancer, non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000030437
- Lead Sponsor
- Osaka medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The person who was not obtained consent of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Microbiota in stool were examined using a next-generation high-speed sequencer before underwent chemotherapy and after two rounds of chemotherapy.
- Secondary Outcome Measures
Name Time Method